The Valley Desk

NCT06830798 · Interventional trial

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

Overall registry status Recruiting

Phase 3

Conditions DGF, Delayed Graft Function, Kidney Transplant

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov